PortfoliosLab logo
AMN vs. MEDP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AMN and MEDP is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

AMN vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AMN Healthcare Services, Inc. (AMN) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

AMN:

68.30%

MEDP:

52.22%

Max Drawdown

AMN:

-1.51%

MEDP:

-3.90%

Current Drawdown

AMN:

0.00%

MEDP:

-1.59%

Fundamentals

Market Cap

AMN:

$840.42M

MEDP:

$8.51B

EPS

AMN:

-$4.33

MEDP:

$13.11

PEG Ratio

AMN:

1.71

MEDP:

3.45

PS Ratio

AMN:

0.29

MEDP:

3.95

PB Ratio

AMN:

1.18

MEDP:

14.53

Total Revenue (TTM)

AMN:

$2.16B

MEDP:

$2.16B

Gross Profit (TTM)

AMN:

$618.77M

MEDP:

$672.28M

EBITDA (TTM)

AMN:

-$56.41M

MEDP:

$484.51M

Returns By Period


AMN

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

MEDP

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AMN vs. MEDP — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMN
The Risk-Adjusted Performance Rank of AMN is 77
Overall Rank
The Sharpe Ratio Rank of AMN is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of AMN is 44
Sortino Ratio Rank
The Omega Ratio Rank of AMN is 55
Omega Ratio Rank
The Calmar Ratio Rank of AMN is 88
Calmar Ratio Rank
The Martin Ratio Rank of AMN is 1414
Martin Ratio Rank

MEDP
The Risk-Adjusted Performance Rank of MEDP is 1818
Overall Rank
The Sharpe Ratio Rank of MEDP is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of MEDP is 2020
Sortino Ratio Rank
The Omega Ratio Rank of MEDP is 1919
Omega Ratio Rank
The Calmar Ratio Rank of MEDP is 1111
Calmar Ratio Rank
The Martin Ratio Rank of MEDP is 2323
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AMN vs. MEDP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AMN Healthcare Services, Inc. (AMN) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

AMN vs. MEDP - Dividend Comparison

Neither AMN nor MEDP has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AMN vs. MEDP - Drawdown Comparison

The maximum AMN drawdown since its inception was -1.51%, smaller than the maximum MEDP drawdown of -3.90%. Use the drawdown chart below to compare losses from any high point for AMN and MEDP. For additional features, visit the drawdowns tool.


Loading data...

Volatility

AMN vs. MEDP - Volatility Comparison


Loading data...

Financials

AMN vs. MEDP - Financials Comparison

This section allows you to compare key financial metrics between AMN Healthcare Services, Inc. and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M400.00M600.00M800.00M1.00B1.20B1.40B1.60B20212022202320242025
734.71M
558.57M
(AMN) Total Revenue
(MEDP) Total Revenue
Values in USD except per share items

AMN vs. MEDP - Profitability Comparison

The chart below illustrates the profitability comparison between AMN Healthcare Services, Inc. and Medpace Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

26.0%28.0%30.0%32.0%34.0%20212022202320242025
29.8%
31.9%
(AMN) Gross Margin
(MEDP) Gross Margin
AMN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AMN Healthcare Services, Inc. reported a gross profit of 218.99M and revenue of 734.71M. Therefore, the gross margin over that period was 29.8%.

MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported a gross profit of 178.35M and revenue of 558.57M. Therefore, the gross margin over that period was 31.9%.

AMN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AMN Healthcare Services, Inc. reported an operating income of -202.55M and revenue of 734.71M, resulting in an operating margin of -27.6%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported an operating income of 113.52M and revenue of 558.57M, resulting in an operating margin of 20.3%.

AMN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AMN Healthcare Services, Inc. reported a net income of -187.53M and revenue of 734.71M, resulting in a net margin of -25.5%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported a net income of 114.60M and revenue of 558.57M, resulting in a net margin of 20.5%.